Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1977 Jun;16(3):928–933. doi: 10.1128/iai.16.3.928-933.1977

Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen.

H J Alter, R H Purcell, J L Gerin, W T London, P M Kaplan, V J McAuliffe, J Wagner, P V Holland
PMCID: PMC421053  PMID: 892901

Abstract

To assess the infectivity of hepatitis B surface antigen (HBsAg)-containing body fluids other than blood, chimpanzees were inoculated intravenously with saliva and semen obtained from HBsAg-positive individuals implicated in non-percutaneous transmission of hepatitis B. Saliva and semen samples were negative for occult blood. The titer of HBsAg in saliva was on the average only 1/3,000 that of the corresponding serum. One chimpanzee, inoculated sequentially with saliva from three individuals, developed HBsAg at 9 weeks and serum glutamic pyruvic transaminase elevation at 13 weeks after injection. HBsAg persisted for 15 weeks. This animal also developed e antigen, anti-core antibody, and anti-surface antibody. Liver biopsies showed acute hepatitis that subsequently resolved. A second chimpanzee, inoculated with HBsAg-positive semen, developed HBsAg and elevated serum glutamic pyruvic transaminase 4 weeks after inoculation and then died suddenly without explanation. HBsAg was positive in two consecutive samples and was confirmed by specific neutralization. Autopsy did not reveal evidence of hepatitis. This study demonstrates that HBsAg-positive saliva and, probably, semen contain infectious virus and suggests that saliva and/or semen may serve as important mechanisms in the transmission of type B hepatitis.

Full text

PDF
928

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bancroft W. H., Snitbhan R., Scott R. M., Tingpalapong M., Watson W. T., Tanticharoenyos P., Karwacki J. J., Srimarut S. Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J Infect Dis. 1977 Jan;135(1):79–85. doi: 10.1093/infdis/135.1.79. [DOI] [PubMed] [Google Scholar]
  2. Barker L. F., Murray R. Aquisition of hepatitis-associated antigen. Clinical features in young adults. JAMA. 1971 Jun 21;216(12):1970–1976. [PubMed] [Google Scholar]
  3. Cherubin C. E., Purcell R. H., Lander J. J., McGinn T. G., Cone L. A. Acquisition of antibody to hepatitis B antigen in three socioeconomically different medical populations. Lancet. 1972 Jul 22;2(7769):149–151. doi: 10.1016/s0140-6736(72)91325-6. [DOI] [PubMed] [Google Scholar]
  4. Feinman S. V., Krassnitski O., Sinclair J. C., Wrobel D. M., Berris B. Hepatitis B surface antigen in saliva of HB-SAg carriers. J Lab Clin Med. 1975 Jun;85(6):1042–1048. [PubMed] [Google Scholar]
  5. Froesner G. G., Peterson D. A., Holmes A. W., Deinhardt F. W. Prevalance of antibody to hepatitis B surface antigen in various populations. Infect Immun. 1975 Apr;11(4):732–736. doi: 10.1128/iai.11.4.732-736.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gerin J. L., Ford E. C., Purcell R. H. Biochemical characterization of Australia antigen. Evidence for defective particles of hepatitis B virus. Am J Pathol. 1975 Dec;81(3):651–668. [PMC free article] [PubMed] [Google Scholar]
  7. Heathcote J., Cameron C. H., Dane D. S. Hepatitis-B antigen in saliva and semen. Lancet. 1974 Jan 19;1(7847):71–73. doi: 10.1016/s0140-6736(74)92289-2. [DOI] [PubMed] [Google Scholar]
  8. Kaplan P. M., Gerin J. L., Alter H. J. Hepatitis B-specific DNA polymerase activity during post-transfusion hepatitis. Nature. 1974 Jun 21;249(459):762–764. doi: 10.1038/249762a0. [DOI] [PubMed] [Google Scholar]
  9. Kaplan P. M., Greenman R. L., Gerin J. L., Purcell R. H., Robinson W. S. DNA polymerase associated with human hepatitis B antigen. J Virol. 1973 Nov;12(5):995–1005. doi: 10.1128/jvi.12.5.995-1005.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Krugman S., Giles J. P. Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention. N Engl J Med. 1973 Apr 12;288(15):755–760. doi: 10.1056/NEJM197304122881503. [DOI] [PubMed] [Google Scholar]
  11. Lander J. J., Alter H. J., Purcell R. H. Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique. J Immunol. 1971 May;106(5):1166–1171. [PubMed] [Google Scholar]
  12. MacQuarrie M. B., Forghani B., Wolochow D. A. Hepatitis B transmitted by a human bite. JAMA. 1974 Nov 4;230(5):723–724. [PubMed] [Google Scholar]
  13. Ogra P. L. Immunologic aspects of hepatitis-associated antigen and antibody in human body fluids. J Immunol. 1973 May;110(5):1197–1205. [PubMed] [Google Scholar]
  14. Prince A. M., Hargrove R. L., Szmuness W., Cherubin C. E., Fontana V. J., Jeffries G. H. Immunologic distinction between infectious and serum hepatitis. N Engl J Med. 1970 Apr 30;282(18):987–991. doi: 10.1056/NEJM197004302821801. [DOI] [PubMed] [Google Scholar]
  15. Purcell R. H., Gerin J. L., Almeida J. B., Holland P. V. Radioimmunoassay for the detection of the core of the Dane particle and antibody to it. Intervirology. 1974;2(4):231–243. doi: 10.1159/000149428. [DOI] [PubMed] [Google Scholar]
  16. Purcell R. H., Gerin J. L. Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees. Am J Med Sci. 1975 Sep-Oct;270(2):395–399. [PubMed] [Google Scholar]
  17. Steinberg S. C., Alter H. J., Leventhal B. G. The risk of hepatitis transmission to family contacts of leukemia patients. J Pediatr. 1975 Nov;87(5):753–756. doi: 10.1016/s0022-3476(75)80300-3. [DOI] [PubMed] [Google Scholar]
  18. Sutnick A. I., London W. T., Gerstley B. J., Cronlund M. M., Blumberg B. S. Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome. JAMA. 1968 Sep 2;205(10):670–674. [PubMed] [Google Scholar]
  19. Szmuness W., Harley E. J., Prince A. M. Intrafamilial spread of asymptomatic hepatitis B. Am J Med Sci. 1975 Sep-Oct;270(2):293–304. doi: 10.1097/00000441-197509000-00009. [DOI] [PubMed] [Google Scholar]
  20. Tsuda F., Takahashi T., Takahashi K., Miyakawa Y., Mayumi M. Determination of antibody to hepatitis B core antigen by means of immune adherence hemagglutination. J Immunol. 1975 Sep;115(3):834–838. [PubMed] [Google Scholar]
  21. Villarejos V. M., Visoná K. A., Gutiérrez A., Rodríguez A. Role of saliva, urine and feces in the transmission of type B hepatitis. N Engl J Med. 1974 Dec 26;291(26):1375–1378. doi: 10.1056/NEJM197412262912602. [DOI] [PubMed] [Google Scholar]
  22. Vyas G. N., Shulman N. R. Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science. 1970 Oct 16;170(3955):332–333. doi: 10.1126/science.170.3955.332. [DOI] [PubMed] [Google Scholar]
  23. Ward R., Borchert P., Wright A., Kline E. Hepatitis B antigen in saliva and mouth washings. Lancet. 1972 Oct 7;2(7780):726–727. doi: 10.1016/s0140-6736(72)92021-1. [DOI] [PubMed] [Google Scholar]
  24. Williams A., Le Bouvier G. Heterogeneity and thermolability of 'e'. Bibl Haematol. 1976;42:71–75. doi: 10.1159/000398996. [DOI] [PubMed] [Google Scholar]
  25. Wright R. A. Hepatitis B and the HB-SAg carrier. An outbreak related to sexual contact. JAMA. 1975 May 19;232(7):717–721. doi: 10.1001/jama.232.7.717. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES